Watson News (NYSE:WPI)
| Latest Watson Pharmaceuticals News Headlines | | Date | Time | Source | | | 08/13/2008 | 9:46PM | PRNUS | Watson Announces District Court Ruling in Naproxen Sodium Patent Suit
CORONA, Calif., Aug. 13 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida ruled today that Watson's Naproxen Sodium ER tablets, the generic version of Naprelan(R), infringes... More...>> |
| 08/06/2008 | 7:00AM | PRNUS | Watson Pharmaceuticals Reports Second Quarter 2008 Results
Total Net Revenue of $623 Million; GAAP EPS $0.53; Adjusted EPS $0.48
CORONA, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, today reported financial results for its second quarter ended June 30, 2008.
Second Quarter 2008 Results
Net revenue... More...>> |
| 08/05/2008 | 8:00AM | PRNUS | Urologists Should Recognize the Cardiac Safety of Prescribed Medications, Article Concludes
- QTc profile particularly important among BPH patients with cardiovascular risk factors -
CORONA, Calif., Aug. 5 /PRNewswire-FirstCall/ -- A paper published in the current issue of Reviews in Urology (2008; 10(2):85-91) concludes that urologists and other physicians treating benign prostatic hyperplasia (BPH) should... More...>> |
| 07/28/2008 | 5:16PM | PRNUS | Mylan Acquires Remaining Interest in Somerset Joint Venture From Watson
PITTSBURGH and CORONA, Calif., July 28 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE:MYL) and Watson Pharmaceuticals, Inc. (NYSE:WPI) announced today that Mylan has acquired Watson's 50 percent interest in the Somerset Pharmaceuticals, Inc. (Somerset) joint venture. Details of the transaction remain confidential.
Somerset... More...>> |
| 07/28/2008 | 8:00AM | PRNUS | Watson Names Clare Carmichael Senior VP Human Resources
CORONA, Calif., July 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, today announced the appointment of Clare Carmichael as Senior Vice President, Human Resources. Ms. Carmichael's appointment follows the planned retirement of long-time industry professional... More...>> |
| 07/25/2008 | 8:00AM | PRNUS | Watson Launches Omeprazole Delayed-Release Capsules, 40MG
- 180-Days of Marketing Exclusivity Begins -
CORONA, Calif., July 25 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that its subsidiary has commenced commercial shipment of its Omeprazole Delayed-Release Capsules USP product in the 40mg... More...>> |
| 06/30/2008 | 1:30AM | PRNUS | Watson Launches Generic MARINOL(R) Capsules
CORONA, Calif., June 30 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that, under a supply agreement with Solvay Pharmaceuticals, Inc., Watson has launched the authorized generic version of dronabinol in the 2.5, 5 and 10 mg once daily... More...>> |
| 06/03/2008 | 7:30AM | PRNUS | Watson Receives FDA Approval of Potassium Chloride Extended-Release Capsules
CORONA, Calif., June 3 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that it has received approval from the U.S. Food and Drug Administration ("FDA") of its Abbreviated New Drug Application (ANDA) for Potassium-Chloride Extended-Release... More...>> |
| 06/02/2008 | 8:00AM | PRNUS | Watson Receives Final Approval of Omeprazole Delayed-Release Capsules
CORONA, Calif., June 2 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that it has received final approval from the U.S. Food and Drug Administration ("FDA") of its Abbreviated New Drug Application (ANDA) for Omeprazole Delayed-Release Capsules... More...>> |
| 05/28/2008 | 3:00AM | PRNUS | Watson Announces Oxybutynin Topical Gel NDA Accepted for Filing by FDA for the Treatment of Overactive Bladder
CORONA, Calif., May 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that its New Drug Application (NDA) for oxybutynin chloride topical gel (OTG), has been accepted for filing by the U.S. Food and Drug Administration (FDA). Watson is seeking... More...>> |
| 05/23/2008 | 5:58PM | PRNUS | Watson to Present at the UBS Global Specialty and Generic Pharmaceuticals Conference
CORONA, Calif., May 23 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the UBS Global Specialty and Generic... More...>> |
| 05/21/2008 | 9:00AM | PRNUS | Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
- Innovative pipeline products highlight Watson's commitment to urology -
ORLANDO, Fla., May 21 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that investigators presented clinical data on two Phase 3 products at the American Urological... More...>> |
| 05/13/2008 | 8:30AM | PRNUS | Watson to Host and Webcast Investment Community Meeting at American Urological Association Annual Meeting
- Company to Highlight Significant and Expanding Commitment to the Treatment of Urological Diseases -
CORONA, Calif., May 13 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that management will host and webcast a meeting for the investment... More...>> |
| 05/12/2008 | 8:00AM | PRNUS | Watson Pharmaceuticals Announces Appointment of Andrew L. Turner as Chairman of the Board of Directors
- Allen Chao, Ph.D., to Resign from the Board of Directors -
CORONA, Calif., May 12 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) announced today that following the Company's Annual Stockholder meeting, Allen Chao, Ph.D., Founder and Chairman of the Board, informed the Company of his decision to... More...>> |
| 05/09/2008 | 4:44PM | PRNUS | Watson to Present at the Bank of America 2008 Healthcare Conference
CORONA, Calif., May 9 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the Bank of America 2008 Healthcare Conference... More...>> |
| 05/06/2008 | 8:00AM | PRNUS | Watson Pharmaceuticals to Webcast Its 2008 Annual Meeting of Stockholders
CORONA, Calif., May 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that the Company will conduct a live webcast of its 2008 Annual Meeting of Stockholders on Friday, May 9, 2008 at 9:00 a.m. Pacific Daylight Time.
The live presentation... More...>> |
| 05/01/2008 | 7:00AM | PRNUS | Watson Pharmaceuticals Reports First Quarter 2008 Results
Total Net Revenue of $627 Million; GAAP EPS $0.45; Adjusted EPS $0.55
CORONA, Calif., May 1 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2008.
First Quarter 2008 Results
Net revenue... More...>> |
| 04/30/2008 | 9:00AM | PRNUS | FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's TRELSTAR(R) DEPOT and TRELS
- New system addresses the needs of the medical community; builds on proven efficacy and safety of TRELSTAR(R) -
CORONA, Calif., April 30 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has approved... More...>> |
| 04/29/2008 | 7:00AM | PRNUS | Watson Announces Removal of FDA Official Action Indicated Status at Its Davie, Florida Facility
- Company Announces Completion of FDA Inspection -
CORONA, Calif., April 29 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration ("FDA") has completed the inspection of the company's Florida manufacturing... More...>> |
| 04/24/2008 | 4:00PM | PRNUS | Watson Files FDA Application for Generic FENTORA(R)
CORONA, Calif., April 24 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, today confirmed that its subsidiary Watson Laboratories, Inc. (a Nevada Corporation) has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration... More...>> |
|
|
|